Home News Oral Apixaban Preferable for Preventing Postsurgery VTE in Patients With Gynecologic Cancer back to News
minute read
Findings from a multi-center clinical trial of patients undergoing surgery for gynecologic cancer showed that oral apixaban was easier and less painful to administer than subcutaneous enoxaparin (JAMA Netw Open. 2020;3[6]:e207410).
Topics: Press Coverage
13001 East 17th Place
Aurora, CO 80045
303.724.5375
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
